These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 1779019
1. Factors associated with diabetic microangiopathy: a study of 157 type I (insulin-dependent) diabetic patients. Billault BM, Passa PL. J Diabet Complications; 1991; 5(4):238-43. PubMed ID: 1779019 [Abstract] [Full Text] [Related]
2. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland. Ebeling P, Koivisto VA. Acta Diabetol; 1997 Mar; 34(1):33-8. PubMed ID: 9134055 [Abstract] [Full Text] [Related]
3. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus. Ak G, Buyukberber S, Sevinc A, Turk HM, Ates M, Sari R, Savli H, Cigli A. J Diabetes Complications; 2001 Mar; 15(3):150-7. PubMed ID: 11358684 [Abstract] [Full Text] [Related]
4. Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors. Valensi P, Giroux C, Seeboth-Ghalayini B, Attali JR. J Diabetes Complications; 1997 Mar; 11(1):27-34. PubMed ID: 9025010 [Abstract] [Full Text] [Related]
5. Risk factors for progression of microvascular complications in the Stockholm Diabetes Intervention Study (SDIS). Reichard P. Diabetes Res Clin Pract; 1992 May; 16(2):151-6. PubMed ID: 1600854 [Abstract] [Full Text] [Related]
6. Increased capillary filtration of albumin in diabetic patients--relation with gender, hypertension, microangiopathy, and neuropathy. Valensi P, Behar A, Attalah M, Cohen-Boulakia F, Pariès J, Attali JR. Metabolism; 1998 May; 47(5):503-7. PubMed ID: 9591738 [Abstract] [Full Text] [Related]
8. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918 [Abstract] [Full Text] [Related]
10. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004 [Abstract] [Full Text] [Related]
15. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962 [Abstract] [Full Text] [Related]
16. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients. Lepore G, Bruttomesso D, Nosari I, Tiengo A, Trevisan R. Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660 [Abstract] [Full Text] [Related]